En este episodio de Cardiosíntesis, exploramos los ensayos clínicos más importantes de este primer día en el ACC 2026 de Nueva Orleans.

- Effects Of Tirzepatide Compared With Dulaglutide On Expanded Cardiorenal Outcomes

- Reliability Of CAC=0 To Exclude Coronary Plaque In Diverse Global Cohorts

- Outcomes In Patients With Atrial Fibrillation Randomized To Receive Left Atrial Appendage Closure Or Oral Anticoagulation: Primary Results Of The CHAMPION-AF Clinical Trial

- Primary Left Ventricular Unloading In Anterior ST-Segment Elevation Myocardial Infarction (STEMI) Without Cardio

genic Shock

- Kardinal: A Phase 2 Study Of Tonlamarsen For The Treatment Of Uncontrolled Hypertension

- Evolocumab In Patients Without Significant Atherosclerosis: Results From VESALIUS-CV